Inventor
DEY FABIAN
CH27 patents
⚠️ This page may combine multiple inventors who share the name “DEY FABIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
13 patentsUS12503471B2Dec 23, 2025
Triazatricycle compounds for the treatment of autoimmune disease
HOFFMANN LA ROCHE0 citations62
US12486273B2Dec 2, 2025
Hydro-1H-pyrrolo[1,2-a]pyrazine compounds for the treatment of autoimmune disease
HOFFMANN LA ROCHE0 citations62
US11713327B2Aug 1, 2023
Heteroaryl heterocyclyl compounds for the treatment of autoimmune disease
HOFFMANN LA ROCHE1 citations62
US11639352B2May 2, 2023
Benzothiazole compounds for the treatment of autoimmune diseases
HOFFMANN LA ROCHE0 citations62
US11046671B2Jun 29, 2021
Dihydropyrimidinyl benzazepine carboxamide compounds
HOFFMANN LA ROCHE0 citations62
US11548884B2Jan 10, 2023
Cyclic amidine compounds for the treatment of autoimmune disease
HOFFMANN LA ROCHE0 citations61
US12252484B2Mar 18, 2025
Pyrazolopyridine compounds for the treatment of autoimmune disease
HOFFMANN LA ROCHE0 citations52
US12157746B2Dec 3, 2024
Tetrahydro-1H-pyrazino[2,1-a]isoindolylquinoline compounds for the treatment of autoimmune disease
HOFFMANN LA ROCHE0 citations52
US10590112B2Mar 17, 2020
Dihydropyrimidinyl benzazepine carboxamide compounds
HOFFMANN LA ROCHE0 citations52
US12421229B2Sep 23, 2025
Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune disease
HOFFMANN LA ROCHE0 citations51
US11952363B2Apr 9, 2024
Piperazine compounds for the treatment of autoimmune disease
HOFFMANN LA ROCHE0 citations50
US11091514B2Aug 17, 2021
Peptide macrocycles and use thereof in the treatment of bacterial infections
HOFFMANN LA ROCHE0 citations49
US10662203B2May 26, 2020
Pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection
HOFFMANN LA ROCHE0 citations38
C4 THERAPEUTICS INC
10 patentsUS11584748B2Feb 21, 2023
Spirocyclic compounds
C4 THERAPEUTICS INC11 citations85
US11254672B2Feb 22, 2022
Dihydrobenzimidazolones for medical treatment
C4 THERAPEUTICS INC7 citations84
US11623929B2Apr 11, 2023
Spirocyclic compounds
C4 THERAPEUTICS INC7 citations74
US11802131B2Oct 31, 2023
Glutarimides for medical treatment
C4 THERAPEUTICS INC4 citations73
US11787802B2Oct 17, 2023
Dihydrobenzimidazolones for medical treatment
C4 THERAPEUTICS INC3 citations72
US11401256B2Aug 2, 2022
Dihydroquinolinones for medical treatment
C4 THERAPEUTICS INC5 citations69
US12227504B2Feb 18, 2025
Spirocyclic compounds
C4 THERAPEUTICS INC0 citations62
US12365681B2Jul 22, 2025
Dihydrobenzimidazolones for medical treatment
C4 THERAPEUTICS INC0 citations61
US12091397B2Sep 17, 2024
Dihydroquinolinones for medical treatment
C4 THERAPEUTICS INC1 citations58
US12528797B2Jan 20, 2026
Heterocyclic compounds for medical treatment
C4 THERAPEUTICS INC0 citations51